Cancer control and complications of salvage local therapy after failure of radiotherapy for prostate cancer: A systematic review

Seminars in Radiation Oncology

Volumn 23, Issue 3, 2013, Pages 222-234

  Parekh, Arti ^a   Graham, Powell L ^a   Nguyen, Paul L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BRACHYTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER THERAPY; CRYOTHERAPY; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; LOCAL THERAPY; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RECTUM INJURY; REVIEW; SALVAGE THERAPY; SYSTEMATIC REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME; ULTRASOUND THERAPY; URETHRA STRICTURE; URINARY TRACT FISTULA; URINE INCONTINENCE;

BRACHYTHERAPY; CRYOTHERAPY; ENDOMETRIAL ABLATION TECHNIQUES; HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; PROSTATECTOMY; PROSTATIC NEOPLASMS; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 84878892418     PISSN: 10534296     EISSN: 15329461     Source Type: Journal    
DOI: 10.1016/j.semradonc.2013.01.006     Document Type: Review

References (76)

1. Shipley W.U., Thames H.D., Sandler H.M., et al. Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. JAMA 1999, 281:1598-1604.
2. Zelefsky M.J., Kuban D.A., Levy L.B., et al. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. Int J Radiat Oncol Biol Phys 2007, 67:327-333.
3. Crook J., Malone S., Perry G., et al. Postradiotherapy prostate biopsies: what do they really mean?. Results for 498 patients. Int J Radiat Oncol Biol Phys 2000, 48:355-367.
4. Mohler J.L., Armstrong A.J., Bahnson R.R., et al. Prostate cancer, version 3.2012 featured updates to the nccn guidelines. J Natl Compr Canc Netw 2012, 10:1081-1087.
5. Zelefsky M.J., Ben-Porat L., Scher H.I., et al. Outcome predictors for the increasing PSA state after definitive external-beam radiotherapy for prostate cancer. J Clin Oncol 2005, 23:826-831.
6. Nguyen P.L., D'Amico A.V., Lee A.K., et al. Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature. Cancer 2007, 110:1417-1428.
7. Kimura M., Mouraviev V., Tsivian M., et al. Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy. BJU Int 2010, 105:191-201.
8. Warmuth M., Johansson T., Mad P. Systematic review of the efficacy and safety of high-intensity focussed ultrasound for the primary and salvage treatment of prostate cancer. Eur Urol 2010, 58:803-815.
9. Lukka H., Waldron T., Chin J., et al. High-intensity focused ultrasound for prostate cancer: a systematic review. Clin Oncol (R Coll Radiol) 2011, 23:117-127.
10. Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology consensus Panel. Int J Radiat Oncol Biol Phys 1997, 37:1035-1041. ASTRO.
11. Roach M., Hanks G., Thames H., et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006, 65:965-974.
12. Jo Y., Fujii T., Hara R., et al. Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after radiotherapy-Preliminary results. BJU Int 2012, 109:835-839.
13. Burri R.J., Stone N.N., Unger P., et al. Long-term outcome and toxicity of salvage brachytherapy for local failure after initial radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2010, 77:1338-1344.
14. Lee H.K., Adams M.T., Motta J. Salvage prostate brachytherapy for localized prostate cancer failure after external beam radiation therapy. Brachytherapy 2008, 7:17-21.
15. Tharp M., Hardacre M., Bennett R., et al. Prostate high-dose-rate brachytherapy as salvage treatment of local failure after previous external or permanent seed irradiation for prostate cancer. Brachytherapy 2008, 7:231-236.
16. Grado G.L., Collins J.M., Kriegshauser J.S., et al. Salvage brachytherapy for localized prostate cancer after radiotherapy failure. Urology 1999, 53:2-10.
17. Koutrouvelis P., Hendricks F., Lailas N., et al. Salvage reimplantation in patient with local recurrent prostate carcinoma after brachytherapy with three dimensional computed tomography-guided permanent pararectal implant. Technol Cancer Res Treat 2003, 2:339-344.
18. Loening S.A., Turner J.W. Use of percutaneous transperineal 198Au seeds to treat recurrent prostate adenocarcinoma after failure of definitive radiotherapy. Prostate 1993, 23:283-290.
19. Nguyen P.L., Chen M.H., D'Amico A.V., et al. Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable-risk prostate cancer: a prospective phase 2 study. Cancer 2007, 110:1485-1492.
20. Lee B., Shinohara K., Weinberg V. Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the university of California-San Francisco experience. Int J Radiat Oncol Biol Phys 2007, 67:1106-1112.
21. Beyer D.C. Permanent brachytherapy as salvage treatment for recurrent prostate cancer. Urology 1999, 54:880-883.
22. Wong W.W., Buskirk S.J., Schild S.E., et al. Combined prostate brachytherapy and short-term androgen deprivation therapy as salvage therapy for locally recurrent prostate cancer after external beam irradiation. J Urol 2006, 176:2020-2024.
23. Dattoli M, Cash J, Ross R, et al: Neoadjuvant hormone therapy and palladium-103 brachytherapy as salvage for locally recurrent prostate cancer. Paper presented at the 33rd annual meeting of the American Society for Clinical Oncology, May 17-20, 1997, Denver, Colorado.
24. Wallner K.E., Nori D., Morse M.J., et al. 125iodine reimplantation for locally progressive prostatic carcinoma. J Urol 1990, 144:704-706.
25. Chauhan S., Patel M.B., Coelho R., et al. Preliminary analysis of the feasibility and safety of salvage robot-assisted radical prostatectomy after radiation failure: multi-institutional perioperative and short-term functional outcomes. J Endourol 2011, 25:1013-1019.
26. Chade D.C., Shariat S.F., Cronin A.M., et al. Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration. Eur Urol 2011, 60:205-210.
27. Ahallal Y., Shariat S.F., Chade D.C., et al. Pilot study of salvage laparoscopic prostatectomy for the treatment of recurrent prostate cancer. BJU Int 2011, 108:724-728.
28. Eandi J.A., Link B.A., Nelson R.A., et al. Robotic assisted laparoscopic salvage prostatectomy for radiation resistant prostate cancer. J Urol 2010, 183:133-137.
29. Leonardo C., Simone G., Papalia R., et al. Salvage radical prostatectomy for recurrent prostate cancer after radiation therapy. Int J Urol 2009, 16:584-586.
30. Seabra D., Faria E., Dauster B., et al. Critical analysis of salvage radical prostatectomy in the management of radioresistant prostate cancer. Int Braz J Urol 2009, 35:43-48.
31. Paparel P., Cronin A.M., Savage C., et al. Oncologic outcome and patterns of recurrence after salvage radical prostatectomy. Eur Urol 2009, 55:404-410.
32. Kaouk J.H., Hafron J., Goel R., et al. Robotic salvage retropubic prostatectomy after radiation/brachytherapy: initial results. BJU Int 2008, 102:93-96.
33. Gotto G.T., Yunis L.H., Vora K., et al. Impact of prior prostate radiation on complications after radical prostatectomy. J Urol 2010, 184:136-142.
34. Younes E., Haas G.P., Montie J.E., et al. Value of preoperative PSA in predicting pathologic stage of patients undergoing salvage prostatectomy. Urology 1994, 43:22-25.
35. Ward J.F., Sebo T.J., Blute M.L., et al. Salvage surgery for radiorecurrent prostate cancer: contemporary outcomes. J Urol 2005, 173:1156-1160.
36. Bianco F.J., Scardino P.T., Stephenson A.J., et al. Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Int J Radiat Oncol Biol Phys 2005, 62:448-453.
37. Stephenson A.J., Scardino P.T., Bianco F.J., et al. Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy. J Urol 2004, 172(6 Pt 1):2239-2243.
38. Sanderson K.M., Penson D.F., Cai J., et al. Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer. J Urol 2006, 176:2025-2031. discussion 2031-2022.
39. Gheiler E.L., Tefilli M.V., Tiguert R., et al. Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate cancer. Urology 1998, 51:789-795.
40. Garzotto M., Wajsman Z. Androgen deprivation with salvage surgery for radiorecurrent prostate cancer: results at 5-year followup. J Urol 1998, 159:950-954. discussion 954-955.
41. van der Poel H.G., Beetsma D.B., van Boven H., et al. Perineal salvage prostatectomy for Radiation resistant prostate cancer. Eur Urol 2007, 51:1565-1571.
42. Link P., Freiha F.S. Radical prostatectomy after definitive radiation therapy for prostate cancer. Urology 1991, 37:189-192.
43. Pisters L.L., English S.F., Scott S.M., et al. Salvage prostatectomy with continent catheterizable urinary reconstruction: a novel approach to recurrent prostate cancer after radiation therapy. J Urol 2000, 163:1771-1774.
44. Stein A., Smith R.B., deKernion J.B. Salvage radical prostatectomy after failure of curative radiotherapy for adenocarcinoma of prostate. Urology 1992, 40:197-200.
45. Moul J.W., Paulson D.F. The role of radical surgery in the management of radiation recurrent and large volume prostate cancer. Cancer 1991, 68:1265-1271.
46. Darras J., Joniau S., Van Poppel H. Salvage radical prostatectomy for radiorecurrent prostate cancer: indications and results. Eur J Surg Oncol 2006, 32:964-969.
47. Dall'Oglio M.F., Barreto F., Paranhos M., et al. Salvage radical prostatectomy: an alternative treatment for local recurrence of radioresistant cancer. Int Braz J Urol 2006, 32:550-556.
48. Vallancien G., Gupta R., Cathelineau X., et al. Initial results of salvage laparoscopic radical prostatectomy after radiation failure. J Urol 2003, 170:1838-1840.
49. Vaidya A., Soloway M.S. Salvage radical prostatectomy for radiorecurrent prostate cancer: morbidity revisited. J Urol 2000, 164:1998-2001.
50. Cresswell J., Asterling S., Chaudhary M., et al. Third-generation cryotherapy for prostate cancer in the UK: a prospective study of the early outcomes in primary and recurrent disease. BJU Int 2006, 97:969-974.
51. Spiess P.E., Lee A.K., Leibovici D., et al. Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy. Cancer 2006, 107:275-280.
52. Ismail M., Ahmed S., Kastner C., et al. Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients. BJU Int 2007, 100:760-764.
53. Pisters L.L., Rewcastle J.C., Donnelly B.J., et al. Salvage prostate cryoablation: initial results from the Cryo On-Line data registry. J Urol 2008, 180:559-564.
54. Pisters L.L., Leibovici D., Blute M., et al. Locally recurrent prostate cancer after initial Radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy. J Urol 2009, 182:517-527.
55. Clarke H.S., Eskridge M.R., El-Zawahry A.M., et al. Salvage cryosurgical ablation of the prostate for local recurrence after radiation therapy: improved outcomes utilizing a capromab pendetide scan and biopsy algorithm. Can J Urol 2007, 14(suppl 1):24-27.
56. Cheetham P., Truesdale M., Chaudhury S., et al. Long-term cancer-specific and overall survival for men followed more than 10 years after primary and salvage cryoablation of the prostate. J Endourol 2010, 24:1123-1129.
57. Truesdale M.D., Cheetham P.J., Hruby G.W., et al. An evaluation of patient selection criteria on predicting progression-free survival after primary focal unilateral nerve-sparing cryoablation for prostate cancer: recommendations for follow up. Cancer J 2010, 16:544-549.
58. Williams A.K., Martínez C.H., Lu C., et al. Disease-free survival following salvage cryotherapy for biopsy-proven radio-recurrent prostate cancer. Eur Urol 2011, 60:405-410.
59. Ng C.K., Moussa M., Downey D.B., Chin J.L. Salvage cryoablation of the prostate: follow up and analysis of predictive factors for outcome. J Urol Oct 2007, 178:1253-1257. discussion 1257.
60. Bahn D.K., Lee F., Silverman P., et al. Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up. Clin Prostate Cancer 2003, 2:111-114.
61. Donnelly B.J., Saliken J.C., Ernst D.S., et al. Role of transrectal ultrasound guided salvage cryosurgery for recurrent prostate carcinoma after radiotherapy. Prostate Cancer Prostatic Dis 2005, 8:235-242.
62. Ghafar M.A., Johnson C.W., De La Taille A., et al. Slavage cryotherapy using an argon based system for Locally recurrent prostate cancer after radiation therapy: the Columbia experience. J Urol 2001, 166:1333-1338.
63. Miller R.J., Cohen J.K., Shuman B., et al. Percutaneous, transperineal cryosurgery of the prostate as salvage therapy for post radiation recurrence of adenocarcinoma. Cancer 1996, 77:1510-1514.
64. Bales G.T., Williams M.J., Sinner M., et al. Short-term outcomes after cryosurgical ablation of the prostate in men with recurrent prostate carcinoma following radiation therapy. Urology 1995, 46:676-680.
65. Han K.R., Cohen J.K., Miller R.J., et al. Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. J Urol 2003, 170:1126-1130.
66. Long J.P., Fallick M.L., LaRock D.R., et al. Preliminary outcomes following cryosurgical ablation of the prostate in patients with clinically localized prostate carcinoma. J Urol 1998, 159:477-484.
67. de la Taille A., Hayek O., Benson M.C., et al. Salvage cryotherapy for recurrent prostate cancer after radiation therapy: the Columbia experience. Urology 2000, 55:79-84.
68. Zacharakis E., Ahmed H.U., Ishaq A., et al. The feasibility and safety of high-intensity focused ultrasound as salvage therapy for recurrent prostate cancer following external beam radiotherapy. BJU Int 2008, 102:786-792.
69. Murat F.J., Poissonnier L., Rabilloud M., et al. Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for Locally Radiorecurrent prostate cancer. Eur Urol 2009, 55:640-649.
70. Berge V., Baco E., Karlsen S.J. A prospective study of salvage high-intensity focused ultrasound for locally radiorecurrent prostate cancer: early results. Scand J Urol Nephrol 2010, 44:223-227.
71. Murota-Kawano A., Nakano M., Hongo S., et al. Salvage high-intensity focused ultrasound for biopsy-confirmed local recurrence of prostate cancer after radical prostatectomy. BJU Int 2010, 105:1642-1645.
72. Uchida T., Shoji S., Nakano M., et al. High-intensity focused ultrasound as salvage therapy for patients with recurrent prostate cancer after external beam radiation, brachytherapy or proton therapy. BJU Int 2011, 107:378-382.
73. Asimakopoulos A.D., Miano R., Virgili G., et al. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study. Urol Oncol 2012, 30:577-583.
74. Gelet A., Chapelon J.Y., Poissonnier L., et al. Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. Urology 2004, 63:625-629.
75. Widmark A., Klepp O., Solberg A., et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet 2009, 373:301-308.
76. Warde P., Mason M., Ding K., et al. Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial. Lancet 2011, 378:2104-2111.